FibroGen Ownership | Who Owns FibroGen?
FibroGen Ownership Summary
FibroGen is owned by 57.15% institutional investors, 0.85% insiders, and 42.00% retail investors. Primecap management co/ca/ is the largest institutional shareholder, holding 13.80% of FGEN shares. Vanguard Capital Opportunity Inv is the top mutual fund, with 3.95% of its assets in FibroGen shares.
FGEN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | FibroGen | 57.15% | 0.85% | 42.00% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Capital Opportunity Inv | 3.96M | 3.95% | -1.26M |
Vanguard Total Stock Mkt Idx Inv | 2.92M | 2.89% | - |
PRIMECAP Odyssey Aggressive Growth | 2.64M | 2.63% | -1.27M |
PRIMECAP Odyssey Growth | 1.57M | 1.56% | -826.01K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.38M | 1.38% | - |
Vanguard Strategic Small-Cap Equity Inv | 898.60K | 0.90% | - |
Fidelity Extended Market Index | 586.66K | 0.58% | 59.66K |
Vanguard US Opportunities Ins USD Acc | 403.52K | 0.40% | -6.00K |
Vanguard Health Care ETF | 320.98K | 0.32% | -824.00 |
NT R2000 Value Index Fund - NL | 308.69K | 0.31% | 34.29K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 12, 2024 | Adib Deyaa | Chief Medical Officer | Buy | $25.88K |
Mar 07, 2024 | Wettig Thane | CEO | Buy | $95.47K |
Sep 01, 2023 | Henderson Jeffrey William | - | Sell | $2.06K |
Aug 04, 2023 | Henderson Jeffrey William | - | Sell | $3.82K |
Jul 11, 2023 | Henderson Jeffrey William | - | Sell | $5.38K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | - |
2024 Q2 | 1 | - |
2024 Q1 | 1 | - |
2023 Q4 | - | - |
2023 Q3 | - | 4 |
FGEN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools